Aristotle University Of Thessaloniki (AUTH)
Μελέτη του βιολογικού ρόλου και της κατανομής των SR πρωτεϊνικών κινασών σε λευχαιμικά κύτταρα
Abstract
dc:descriptionSerine/arginine protein kinases (SR-Protein Kinases) represent a novel class of enzymes that specifically phosphorylate RS or SR dipeptides. They show a remarkable specificity as mutations of Ser to Thr or Arg to Lys in the RS domain of their substrates, completely abrogate phosphorylation. SRPKs have been conserved throughout evolution and so far approximately 15 distinct genes encoding members of this family have been identified in the genomes of mammals, yeast, fruit fly, nematode, and plants. Mammalian SRPK1 was initially purified and cloned by Gui and Fu (1994), on the basis of its ability to phosphorylate members of the SR family of splicing factors in vitro. Since then, SRPK1 has been implicated in the regulation of multiple cellular processes such as chromatin structure, nuclear import and germ cell development. SRPK1a is an alternative spliced form of SRPK1 that contains an extended N-terminal domain of 171 aminoacids. SRPK1a is much less studied than its isoform SRPK1 and up to the present study it had only been detected in human testis. K562 cells have been used in the past as a model system to study CML. In addition, they contain high levels of SRPKs, while SRPK1 has been suggested to act downstream of BCR-Abl, in the same signalling pathway. Taken together these observations lead us to study SRPK1 and SRPK1a in leukaemic cells. Contrary to previous work showing cytoplasmic localization of SRPKs in HeLa cells, we demonstrate in the present study that SRPK1 and SRPK1a mainly partition between the nucleus and the Golgi apparatus in human and mouse leukemic cells. A fraction of the membrane-associated kinase is localised in detergent-resistant lipid rafts. Furthermore, hemin/DMSO or sodium butyrate-induced differentiation of K562 cells and hexamethylenebisacetamide (HMBA)-induced differentiation of MEL cells results in the exclusion of SRPKs from the cell nucleus and their accumulation at the Golgi membrane and the cytoplasm. Proapoptotic K562 cells, after short treatment with imatinib, also display a non-nuclear localization of SRPKs, similar to the one observed in differentiated cells. Moreover, we show that SRPK1 is the predominant isoform in K562 cells, with the expression ratio of the two isoforms being critical in determining cell fate. Stable overexpression of SRPK1a results in its accumulation at the Golgi membrane and the cytoplasm and induces erythroid differentiation of K562 cells. The induction of globin synthesis was accompanied by a marked decrease in proliferation and a significantly reduced clonogenic potential. These findings suggest that SRPK1a may play an important role in linking signaling to erythroid differentiation in human leukemic cells. In order to further probe into the biological roles of SRPKs in leukaemic cells, we studied the in vivo action of several quinoxaline derivatives that were found to selectively inhibit in vitro the phosphorylation activity of SRPK1. 2,3-di(thiophen-2-yl)benzo[g]quinoxaline and a yet uncharacterized compound (ID:14385) exhibited a strong apoptotic activity in K562 and MEL cells. Most interestingly, their action is restricted only against erythroleukaemic cells, whereas they show no effect on several other cancer cell lines, such as 293Τ, U87 και JM1 cells. K562 cells that overexpress SRPK1a show remarkable resistance against the apoptotic action of these inhibitors. This may be due either to the overexpression of the enzyme or the differentiation state of these cells. In line with the last hypothesis, we observed that hemin/DMSO-differentiated K562 cells show equal or even more persistent resistance against the apoptotic action of the same substances. In addition K562 cells overexpressing SRPK1a and hemin/DMSO-differentiated K562 cells were able to overcome the effect of other apoptotic inducers, such as imatinib. Taken together these data suggest that differentiation may activate an anti-apoptotic pathway in leukaemic cells.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2008
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Sanidas, Ioannis
- Σανίδας, Ιωάννης
Subjects
dc:subject × 16Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/19149